1. Home
  2. FF vs ABOS Comparison

FF vs ABOS Comparison

Compare FF & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FutureFuel Corp.

FF

FutureFuel Corp.

HOLD

Current Price

$4.82

Market Cap

212.3M

Sector

Industrials

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.20

Market Cap

197.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FF
ABOS
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.3M
197.9M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
FF
ABOS
Price
$4.82
$2.20
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
275.9K
351.3K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
5.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.09
$1.19
52 Week High
$5.24
$3.60

Technical Indicators

Market Signals
Indicator
FF
ABOS
Relative Strength Index (RSI) 59.10 42.34
Support Level $4.00 $2.13
Resistance Level $5.10 $2.45
Average True Range (ATR) 0.21 0.15
MACD 0.01 -0.02
Stochastic Oscillator 50.00 14.13

Price Performance

Historical Comparison
FF
ABOS

About FF FutureFuel Corp.

FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuels segment sells biodiesel and other petroleum products, with fuels made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment, which generates the majority of revenue, sells products used in the production of agricultural chemicals, including herbicides, as well as coatings and cleaning products such as detergents.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: